241 ZiX.MukhtarH.AgarwalR
LscherWPotschkaH
Additional Tips: Use consistently for best results
W.ChaddockL.HeoS.McLarenM.et al (2010)
The non-L1 GUS enzymes processed DCF-G slower than all of the L1 GUS enzymes tested, with the exception of Bf GUS, which cleaved DCF-G at a rate of 15.1 s 1 , and Bu GUS, which cleaved DCF-G at a rate equal to that of Lr GUS
Landscapes Health & Medical Sciences (AREA) Chemical & Material Sciences (AREA) Organic Chemistry (AREA) Life Sciences & Earth Sciences (AREA) General Health & Medical Sciences (AREA) Medicinal Chemistry (AREA) Bioinformatics & Cheminformatics (AREA) Engineering & Computer Science (AREA) Veterinary Medicine (AREA) Animal Behavior & Ethology (AREA) Public Health (AREA) Pharmacology & Pharmacy (AREA) Chemical Kinetics & Catalysis (AREA) General Chemical & Material Sciences (AREA) Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA) Neurology (AREA) Biomedical Technology (AREA) Neurosurgery (AREA) Proteomics, Peptides & Aminoacids (AREA) Biochemistry (AREA) Molecular Biology (AREA) Genetics & Genomics (AREA) Biophysics (AREA) Crystallography & Structural Chemistry (AREA) Orthopedic Medicine & Surgery (AREA) Psychiatry (AREA) Psychology (AREA) Ophthalmology & Optometry (AREA) Physical Education & Sports Medicine (AREA) Hospice & Palliative Care (AREA) Dermatology (AREA) Epidemiology (AREA) Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA) Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA) Peptides Or Proteins (AREA) Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA) Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA) Abstract The present technology relates to compounds, kits, compositions, and methods useful for the treatment of numerous pathologies including dementia, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other neurodegenerative diseases, spinal cord injury, traumatic brain injury, diabetes and metabolic syndrome, defective wound healing, and/or sensorineural hearing and vision loss
